Pittsburgh, PA,
02
February
2026
|
14:00
Europe/Amsterdam

Non-electric infusion system for extreme environments features proven medical-grade polycarbonate from Covestro

Infused with innovation

Summary
  • Developed with U.S. military partners, the EZfuser™ delivers drugs reliably
  • Makrolon® polycarbonate provides durability in harsh environments 

Delivering life-saving medications in emergency and battlefield conditions—where electricity may not be available —is where traditional infusion methods using either electric pumps or gravity-fed bags will fall short. Recognizing this need, MonuMedical LLC developed the EZfuser™, an innovative single-use syringe pump infuser designed for out-of-hospital care settings. 

Engineered with a medical-grade Makrolon® polycarbonate from Covestro, the EZfuser™ sets a new standard for rugged, reliable, and gamma-stable medical devices. According to MonuMedical, it is the first wearable, compact, disposable, and non-electric infusion device designed to deliver medications in environments where electronic pumps are unavailable—such as military operations, EMS and home infusion settings. 

MonuMedical LLC developed the EZfuser™ in partnership with the U.S. Air Force to withstand extreme conditions while still meeting rigorous requirements for medical devices. The company turned to Covestro for its Makrolon® polycarbonate materials, which contribute to the ruggedness through high-impact resistance and still meet added requirements of being sterilized by gamma radiation and ultrasonically welded. Covestro also provided additional support in selecting custom colors that met regulatory requirements for various components. 

“

“We saw a need in the field for a reliable, portable infusion device. Covestro’s expertise in material science helped us bring this vision to life, ensuring the EZfuser™ meets the rigorous demands of out-of-hospital care.”

David Duncan, MD, founder of MonuMedical LLC
„

Makrolon® Rx2530 polycarbonate offers a unique combination of properties that make it ideal for demanding medical applications: 

  • Dimensional and thermal stability in different environments
  • Sterilizable by steam and high-energy radiation
  • Meeting ISO 10993 biocompatibility requirements
  • Compatible with secondary processes like ultrasonic welding
“

“This collaboration exemplifies how teams come together to address unmet needs in healthcare, especially in environments where reliability and resilience are non-negotiable.”

Emily Shaffer, Healthcare Market Manager, Americas – Engineering Plastics, Covestro LLC
„

The EZfuser™ is expected to launch in the United States in 2026, with expansion in other countries in 2027. 

Visit Covestro at MD&M West 2026, Booth #2439, to learn more about how its materials are pushing boundaries in healthcare innovation. 

Download
Boilerplate

About Covestro: 
Covestro is one of the world’s leading manufacturers of high-quality polymer materials and their components. With its innovative products, processes and methods, the company helps enhance sustainability and the quality of life in many areas. Covestro supplies customers around the world in key industries such as mobility, building and living, as well as the electrical and electronics sector. In addition, polymers from Covestro are also used in sectors such as sports and leisure, telecommunications and health, as well as in the chemical industry itself.

The company is geared completely to the circular economy. In addition, Covestro aims to achieve climate neutrality for its Scope 1 and Scope 2 emissions by 2035, and the Group’s Scope 3 emissions are also set to be climate neutral by 2050. Covestro generated sales of EUR 14.2 billion in fiscal year 2024. At the end of 2024, the company had 46 production sites worldwide and employed approximately 17,500 people (calculated as full-time equivalents).

Forward-Looking Statements 
This news release may contain forward-looking statements based on current assumptions and forecasts made by Covestro AG. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Covestro’s public reports which are available at www.covestro.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. 

Makrolon® is a registered trademark of Covestro Group.